Tabrecta (capmatinib) for the Treatment of Non-Small Cell Lung Cancer (NSCLC)

Image 1-TABRECTA
Tabrecta™ (capmatinib) is a prescription medicine used to treat metastatic non-small cell lung cancer (NSCLC). Credit: Novartis Pharmaceuticals Corporation.